ANGES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.194 EUR | +3.19% |
|
-1.02% | -51.50% |
| Sales 2022 | 67M 424K 389K | Sales 2023 | 152M 962K 883K | Capitalization | 14.23B 90.08M 82.61M |
|---|---|---|---|---|---|
| Net income 2022 | -14.71B -93.15M -85.43M | Net income 2023 | -7.44B -47.08M -43.18M | EV / Sales 2022 | 165 x |
| Net cash position 2022 | 9.88B 62.56M 57.37M | Net cash position 2023 | 3.8B 24.05M 22.06M | EV / Sales 2023 | 68.6 x |
| P/E ratio 2022 |
-1.29
x | P/E ratio 2023 |
-1.83
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 97.13% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +3.19% | ||
| 1 week | -1.02% | ||
| Current month | -5.83% | ||
| 1 month | -6.73% | ||
| 3 months | -31.21% | ||
| 6 months | -52.22% | ||
| Current year | -51.50% |
1 week
0.19
0.19
1 month
0.190.22
Current year
0.190.54
1 year
0.190.60
3 years
0.196.20
5 years
0.1919.30
10 years
0.1919.30
| Managers | Title | Age | Since |
|---|---|---|---|
Tetsuji Yoneo
DFI | Director of Finance/CFO | 54 | 12-09-30 |
Ei Yamada
PSD | President | 74 | 01-04-30 |
Kazuo Suzuki
CTO | Chief Tech/Sci/R&D Officer | 67 | 19-01-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ei Yamada
PSD | President | 74 | 01-04-30 |
Makoto Hara
BRD | Director/Board Member | 73 | 18-03-28 |
Junichi Komamura
BRD | Director/Board Member | 74 | 12-02-29 |
| Date | Price | Change |
|---|---|---|
| 24-07-12 | 0.194 | +3.19% |
| 24-07-11 | 0.188 | -2.08% |
| 24-07-10 | 0.192 | +1.05% |
| 24-07-09 | 0.19 | 0.00% |
| 24-07-08 | 0.19 | -3.06% |
Delayed Quote Deutsche Boerse AG, July 12, 2024 at 03:41 pm EDT
More quotes
AnGes, Inc., formerly AnGes MG, Inc., is a Japan-based company mainly engaged in the development of genetic medicines. The Company is involved in the development of hepatocyte growth factor (HGF) genetic medicines, NF-KB decoy oligo and hemagglutinating virus of Japan envelope (HVJ-E) non-viral vector, among others. As of December 31, 2012, the Company had four consolidated subsidiaries. On January 31, 2013, the Company sold a 95.3% stake of a Osaka-based subsidiary to ISHIHARA SANGYO KAISHA LTD.
Calendar
2024-08-08
- Q2 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| +20.12% | 126B | |
| +25.25% | 119B | |
| +25.56% | 27.95B | |
| -19.51% | 20.5B | |
| -14.36% | 17.12B | |
| -15.63% | 16.1B | |
| -46.67% | 14.97B | |
| +11.89% | 14.84B | |
| +57.74% | 14.38B |
- Stock Market
- Equities
- 4563 Stock
- AJW Stock
